These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17149662)

  • 21. Best practices for managing quality and safety of foreign particles in orally inhaled and nasal drug products, and an evaluation of clinical relevance.
    Blanchard J; Coleman J; Crim C; Dabreu-Hayling C; Fries L; Ghaderi R; Haeberlin B; Malcolmson R; Mittelman S; Nagao L; Saracovan I; Shtohryn L; Snodgrass-Pilla C; Sundahl M; Wolff R
    Pharm Res; 2007 Mar; 24(3):471-9. PubMed ID: 17252189
    [No Abstract]   [Full Text] [Related]  

  • 22. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a Logic Model for Promoting Incorporation of the Concepts of Impurity-Related ICH Guidelines into Pharmacopoeias Based on Cause and Effect Analysis.
    Matsuhama M; Saito R; Miyazaki S
    Chem Pharm Bull (Tokyo); 2020; 68(11):1034-1048. PubMed ID: 33132370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral safety and extraneous agents testing for veterinary vaccines: rationale for requirements, the European approach.
    Bruckner L
    Biologicals; 2010 May; 38(3):338-9. PubMed ID: 20335051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Present situation and prospect of quality standardization of Chinese patent medicines].
    Gao XM; Zhang JJ; Zhang DQ; Wang JX; Ou LN; Chen SH
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):868-72. PubMed ID: 17639993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality standards of the European Pharmacopoeia.
    Bouin AS; Wierer M
    J Ethnopharmacol; 2014 Dec; 158 Pt B():454-7. PubMed ID: 25043777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International specification setting--EP perspectives. European Pharmacopoeia.
    Calam DH
    Dev Biol (Basel); 2002; 107():129-34. PubMed ID: 12079187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The GDR pharmacopoeia--present situation and outlook with special consideration of quality control].
    Wagler M
    Pharmazie; 1989 Jun; 44(6):386-9. PubMed ID: 2672045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Findings on the heavy metal content in herbal drugs and essential oils - an update.
    Albert H; Klier B; Knödler M; Steinhoff B
    Pharmeur Bio Sci Notes; 2018; 2018():62-111. PubMed ID: 30272556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptance criteria for levels of hydrazine in substances for pharmaceutical use and analytical methods for its determination.
    Kean T; Miller JH; Skellern GG; Snodin D
    Pharmeur Sci Notes; 2006 Dec; 2006(2):23-33. PubMed ID: 17691211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of the Pharmacopoeia Committee of the Ministry of Public Health of the USSR in improving drug preparation quality].
    Oboĭmakova OM
    Farm Zh; 1977; 32(4):28-31. PubMed ID: 913542
    [No Abstract]   [Full Text] [Related]  

  • 32. [Quo vadis, Pharmacopoeia Hungarica?].
    Kószeginé SH; Török I; Lipták J; Paál T
    Acta Pharm Hung; 2001; 71(1):99-103. PubMed ID: 11769103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examination of microbiological quality of pharmaceutical raw materials.
    Bomblies L; Weiss C; Beckmann G
    Pharmeur Sci Notes; 2007 Sep; 2007(1):1-7. PubMed ID: 17993088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Testing of medicinal products produced from pooled plasma].
    Unkelbach U; Hunfeld A; Breitner-Ruddock S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1181-4. PubMed ID: 25213735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The harmonization of the regulation of blood products: a European perspective.
    Seitz R; Heiden M; Nübling CM; Unger G; Löwer J
    Vox Sang; 2008 May; 94(4):267-76. PubMed ID: 18179678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality control analytical methods: microbial limit tests for nonsterile pharmaceuticals, Part 1.
    Vu N; Lou JR; Kupiec TC
    Int J Pharm Compd; 2014; 18(3):213-21. PubMed ID: 25306769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiological quality of pharmaceutical raw materials.
    de la Rosa MC; Medina MR; Vivar C
    Pharm Acta Helv; 1995 Sep; 70(3):227-32. PubMed ID: 7480068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tracing and control of raw materials sourcing for vaccine manufacturers.
    Faretra Peysson L
    Biologicals; 2010 May; 38(3):352-3. PubMed ID: 20335052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.